The prognostic impact of lead times in colorectal cancer patients undergoing cytoreductive surgery and HIPEC
Abstract Background National lead time goals have been implemented across Sweden to standardize and improve cancer patient care. However, the prognostic impact of lead times has not yet been studied in patients with colorectal cancer and peritoneal metastases scheduled for cytoreductive surgery and...
Main Authors: | Ylva Jansson, Wilhelm Graf, Lana Ghanipour |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-022-02765-1 |
Similar Items
-
Conversion Surgery with HIPEC for Peritoneal Oligometastatic Gastric Cancer
by: Jerzy Mielko, et al.
Published: (2019-11-01) -
Can Elderly Patients with Peritoneal Metastasis Induced by Appendiceal or Colorectal Tumours Benefit from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
by: Zhou S, et al.
Published: (2021-03-01) -
Systemic Chemotherapy in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery: Systematic Review and Meta-Analysis
by: Marco Tonello, et al.
Published: (2024-03-01) -
Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence
by: Enrico Maria Pasqual, et al.
Published: (2023-01-01) -
Hyperthermic intraperitoneal chemotherapy following up-front cytoreductive surgery versus cytoreductive surgery alone for isolated synchronous colorectal peritoneal metastases: A retrospective, observational study
by: Xiusen Qin, et al.
Published: (2022-10-01)